{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T21:50:51Z","timestamp":1778190651298,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-04803-6","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T19:03:27Z","timestamp":1770404607000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of long cardiac troponin T forms with adverse long-term outcomes in patients with advanced chronic kidney disease"],"prefix":"10.1186","volume":"27","author":[{"given":"Selma","family":"Salonen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Kaipainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Hakam\u00e4ki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niilo","family":"Liuhto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noora","family":"Manni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomi","family":"Toukola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonna","family":"Virtanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roosa","family":"Lankinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaj","family":"Mets\u00e4rinne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuija","family":"Vasankari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. E. Juhani","family":"Airaksinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikko J.","family":"J\u00e4rvisalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saara","family":"Wittfooth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9453-5687","authenticated-orcid":false,"given":"Tapio","family":"Hellman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"4803_CR1","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","volume":"72","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72:2231\u201364.","journal-title":"J Am Coll Cardiol"},{"key":"4803_CR2","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1373\/clinchem.2012.185322","volume":"58","author":"C DeFilippi","year":"2012","unstructured":"DeFilippi C, Seliger SL, Kelley W, Duh S-H, Hise M, Christenson RH, et al. Interpreting cardiac troponin results from high-sensitivity assays in chronic kidney disease without acute coronary syndrome. Clin Chem. 2012;58:1342\u201351.","journal-title":"Clin Chem"},{"key":"4803_CR3","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1161\/CIRCULATIONAHA.117.029986","volume":"136","author":"N van der Linden","year":"2017","unstructured":"van der Linden N, Cornelis T, Kimenai DM, Klinkenberg LJJ, Hilderink JM, L\u00fcck S, et al. Origin of cardiac troponin T elevations in chronic kidney disease. Circulation. 2017;136:1073\u201375.","journal-title":"Circulation"},{"key":"4803_CR4","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.clinbiochem.2017.02.007","volume":"50","author":"V Frid\u00e9n","year":"2017","unstructured":"Frid\u00e9n V, Starnberg K, Muslimovic A, Ricksten S-E, Bjurman C, Forsgard N, et al. Clearance of cardiac troponin T with and without kidney function. Clin Biochem. 2017;50:468\u201374.","journal-title":"Clin Biochem"},{"key":"4803_CR5","doi-asserted-by":"publisher","first-page":"6791","DOI":"10.1038\/s41598-020-63744-8","volume":"10","author":"A Muslimovic","year":"2020","unstructured":"Muslimovic A, Frid\u00e9n V, Tenstad O, Starnberg K, Nystr\u00f6m S, Wes\u00e9n E, et al. The liver and kidneys mediate clearance of cardiac troponin in the rat. Sci Rep. 2020;10:6791.","journal-title":"Sci Rep"},{"key":"4803_CR6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1053\/j.ajkd.2021.06.017","volume":"79","author":"N Bansal","year":"2022","unstructured":"Bansal N, Zelnick LR, Ballantyne CM, Chaves PHM, Christenson RH, Coresh J, et al. Upper reference limits for high-sensitivity cardiac troponin T and N-terminal fragment of the prohormone brain natriuretic peptide in patients with CKD. Am J Kidney Dis. 2022;79:383\u201392.","journal-title":"Am J Kidney Dis"},{"key":"4803_CR7","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.clinbiochem.2007.04.004","volume":"40","author":"ECHJ Michielsen","year":"2007","unstructured":"Michielsen ECHJ, Diris JHC, Kleijnen VWVC, Wodzig WKWH, Van Dieijen-Visser MP. Investigation of release and degradation of cardiac troponin T in patients with acute myocardial infarction. Clin Biochem. 2007;40:851\u201355.","journal-title":"Clin Biochem"},{"key":"4803_CR8","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1373\/clinchem.2012.200543","volume":"59","author":"EPM Cardinaels","year":"2013","unstructured":"Cardinaels EPM, Mingels AMA, van Rooij T, Collinson PO, Prinzen FW, van Dieijen-Visser MP. Time-dependent degradation pattern of cardiac troponin T following myocardial infarction. Clin Chem. 2013;59:1083\u201390.","journal-title":"Clin Chem"},{"key":"4803_CR9","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1373\/clinchem.2018.301127","volume":"65","author":"AV Vylegzhanina","year":"2019","unstructured":"Vylegzhanina AV, Kogan AE, Katrukha IA, Koshkina EV, Bereznikova AV, Filatov VL, et al. Full-size and partially truncated cardiac troponin complexes in the blood of patients with acute myocardial infarction. Clin Chem. 2019;65:882\u201392.","journal-title":"Clin Chem"},{"key":"4803_CR10","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1373\/clinchem.2016.261644","volume":"63","author":"AMA Mingels","year":"2017","unstructured":"Mingels AMA, Cardinaels EPM, Broers NJH, van Sleeuwen A, Streng AS, van Dieijen-Visser MP, et al. Cardiac troponin T: smaller molecules in patients with end-stage renal disease than after onset of acute myocardial infarction. Clin Chem. 2017;63:683\u201390.","journal-title":"Clin Chem"},{"key":"4803_CR11","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1161\/CIRCULATIONAHA.122.060845","volume":"146","author":"KEJ Airaksinen","year":"2022","unstructured":"Airaksinen KEJ, Aalto R, Hellman T, Vasankari T, Lahtinen A, Wittfooth S. Novel troponin fragmentation assay to discriminate between troponin elevations in acute myocardial infarction and end-stage renal disease. Circulation. 2022;146:1408\u201310.","journal-title":"Circulation"},{"key":"4803_CR12","first-page":"782","volume":"13","author":"KEJ Airaksinen","year":"2024","unstructured":"Airaksinen KEJ, Tuominen T, Paana T, Hellman T, Vasankari T, Salonen S, et al. Novel troponin fragmentation assay to discriminate between Takotsubo syndrome and acute myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2024;13:782\u201388.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"4803_CR13","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1373\/jalm.2018.027144","volume":"3","author":"WHM Vroemen","year":"2019","unstructured":"Vroemen WHM, Mezger STP, Masotti S, Clerico A, Bekers O, de Boer D, et al. Cardiac troponin T: only small molecules in recreational runners after marathon completion. J Appl Lab Med. 2019;3:909\u201311.","journal-title":"J Appl Lab Med"},{"key":"4803_CR14","doi-asserted-by":"publisher","first-page":"e002954","DOI":"10.1136\/openhrt-2024-002954","volume":"11","author":"KEJ Airaksinen","year":"2024","unstructured":"Airaksinen KEJ, Paana T, Vasankari T, Salonen S, Tuominen T, Linko-Parvinen A, et al. Composition of cardiac troponin release differs after marathon running and myocardial infarction. Open Heart. 2024;11:e002954.","journal-title":"Open Heart"},{"key":"4803_CR15","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1093\/clinchem\/hvae075","volume":"70","author":"SM Salonen","year":"2024","unstructured":"Salonen SM, Tuominen TJK, Raiko KIS, Vasankari T, Aalto R, Hellman TA, et al. Highly sensitive immunoassay for long forms of cardiac troponin T using upconversion luminescence. Clin Chem. 2024;70:1037\u201345.","journal-title":"Clin Chem"},{"key":"4803_CR16","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.hrthm.2019.08.015","volume":"17","author":"SE Janus","year":"2020","unstructured":"Janus SE, Hajjari J, Al-Kindi S. High sensitivity troponin and the risk of atrial fibrillation in chronic kidney disease: results from the Chronic Renal Insufficiency Cohort (CRIC) study. Heart Rhythm. 2020;17:190\u201394.","journal-title":"Heart Rhythm"},{"key":"4803_CR17","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.cca.2010.03.004","volume":"411","author":"D McGill","year":"2010","unstructured":"McGill D, Talaulikar G, Potter JM, Koerbin G, Hickman PE. Over time, high-sensitivity TnT replaces NT-proBNP as the most powerful predictor of death in patients with dialysis-dependent chronic renal failure. Clin Chim Acta. 2010;411:936\u201339.","journal-title":"Clin Chim Acta"},{"key":"4803_CR18","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1001\/jama.2010.1768","volume":"304","author":"JA de Lemos","year":"2010","unstructured":"de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA. 2010;304:2503\u201312.","journal-title":"JAMA"},{"key":"4803_CR19","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1161\/CIRCULATIONAHA.110.005264","volume":"123","author":"JT Saunders","year":"2011","unstructured":"Saunders JT, Nambi V, de Lemos JA, Chambless LE, Virani SS, Boerwinkle E, et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities study. Circulation. 2011;123:1367\u201376.","journal-title":"Circulation"},{"key":"4803_CR20","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1159\/000509582","volume":"51","author":"R Lankinen","year":"2020","unstructured":"Lankinen R, Hakam\u00e4ki M, Mets\u00e4rinne K, Koivuviita NS, P\u00e4rkk\u00e4 JP, Hellman T, et al. Cardiovascular determinants of mortality in advanced chronic kidney disease. Am J Nephrol. 2020;51:726\u201335.","journal-title":"Am J Nephrol"},{"key":"4803_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000511451","volume":"145","author":"M Hakam\u00e4ki","year":"2021","unstructured":"Hakam\u00e4ki M, Hellman T, Lankinen R, Koivuviita N, P\u00e4rkk\u00e4 J, Kallio P, et al. Elevated troponin T and enlarged left atrium are associated with the incidence of atrial fibrillation in patients with CKD stage 4-5. Nephron. 2021;145:71\u201377.","journal-title":"Nephron"},{"key":"4803_CR22","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","volume":"341","author":"RA Wolfe","year":"1999","unstructured":"Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LYC, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341:1725\u201330.","journal-title":"N Engl J Med"},{"key":"4803_CR23","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1159\/000521771","volume":"146","author":"M Hakam\u00e4ki","year":"2022","unstructured":"Hakam\u00e4ki M, J\u00e4rvisalo MJ, Lankinen R, Koivuviita N, P\u00e4rkk\u00e4 JP, Kozak-Barany A, et al. Evolution of quality of life in chronic kidney disease stage 4\u20135 patients transitioning to dialysis and transplantation. Nephron. 2022;146:439\u201348.","journal-title":"Nephron"},{"key":"4803_CR24","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/joim.12406","volume":"278","author":"GK Hansson","year":"2015","unstructured":"Hansson GK, Libby P, Tabas I. Inflammation and plaque vulnerability. J Intern Med. 2015;278:483\u201393.","journal-title":"J Intern Med"},{"key":"4803_CR25","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1097\/SHK.0000000000000811","volume":"47","author":"M Ostermann","year":"2017","unstructured":"Ostermann M, Ayis S, Tuddenham E, Lo J, Lei K, Smith J, et al. Cardiac troponin release is associated with biomarkers of inflammation and ventricular dilatation during critical illness. Shock. 2017;47:702\u201308.","journal-title":"Shock"},{"key":"4803_CR26","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1097\/01.TP.0000157773.96534.29","volume":"79","author":"EM Simmons","year":"2005","unstructured":"Simmons EM, Langone A, Sezer MT, Vella JP, Recupero P, Morrow JD, et al. Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients. Transplantation. 2005;79:914\u201319.","journal-title":"Transplantation"},{"key":"4803_CR27","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.34067\/KID.0002472021","volume":"2","author":"JH Wang","year":"2021","unstructured":"Wang JH, Hart A. Global perspective on kidney transplantation: United States. Kidney360. 2021;2:1836\u201339.","journal-title":"Kidney360"},{"key":"4803_CR28","first-page":"553","volume":"7","author":"J Mair","year":"2018","unstructured":"Mair J, Lindahl B, Hammarsten O, M\u00fcller C, Giannitsis E, Huber K, et al. How is cardiac troponin released from injured myocardium? Eur Heart J Acute Cardiovasc Care. 2018;7:553\u201360.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"4803_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ahj.2014.10.005","volume":"169","author":"KB Filion","year":"2015","unstructured":"Filion KB, Agarwal SK, Ballantyne CM, Eberg M, Hoogeveen RC, Huxley RR, et al. High-sensitivity cardiac troponin T and the risk of incident atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2015;169:31\u20138.e3.","journal-title":"Am Heart J"},{"key":"4803_CR30","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1161\/01.CIR.0000058743.15215.03","volume":"107","author":"H Sinno","year":"2003","unstructured":"Sinno H, Derakhchan K, Libersan D, Merhi Y, Leung TK, Nattel S. Atrial ischemia promotes atrial fibrillation in dogs. Circulation. 2003;107:1930\u201336.","journal-title":"Circulation"},{"key":"4803_CR31","doi-asserted-by":"publisher","first-page":"120419","DOI":"10.1016\/j.cca.2025.120419","volume":"576","author":"T Tuominen","year":"2025","unstructured":"Tuominen T, Vasankari T, Junes H, Salonen S, Teppo K, Linko-Parvinen A, et al. Long cardiac troponin T forms in a healthy reference population. Clin Chim Acta. 2025;576:120419.","journal-title":"Clin Chim Acta"},{"key":"4803_CR32","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1016\/j.hrthm.2024.04.083","volume":"21","author":"A Relander","year":"2024","unstructured":"Relander A, Ruohonen I, Jaakkola S, Vasankari T, Nuotio I, Airaksinen KEJ, et al. Novel electrocardiographic classification for stroke prediction in atrial fibrillation patients undergoing cardioversion. Heart Rhythm. 2024;21:2407\u201318.","journal-title":"Heart Rhythm"},{"key":"4803_CR33","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.hlc.2017.04.007","volume":"27","author":"H Zhang","year":"2018","unstructured":"Zhang H, Li J, Chen X, Wu N, Xie W, Tang H, et al. Association of systemic inflammation score with atrial fibrillation: a case-control study with propensity score matching. Heart Lung Circ. 2018;27:489\u201396.","journal-title":"Heart Lung Circ"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-04803-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04803-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04803-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T13:00:51Z","timestamp":1773061251000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-04803-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4803"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-04803-6","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"19 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol (reference No. T05\/024\/20) was approved by the Medical Ethics Committee of the Hospital District of Southwest Finland and the study was conducted in accordance with the Declaration of Helsinki. All participants provided a written informed consent before entering the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SS has received support from the Doctoral Programme in Clinical Research of the University of Turku, grants from the Turku University Foundation, the Varsinais-Suomi Regional Fund of the Finnish Cultural Foundation, and the Laboratoriol\u00e4\u00e4ketieteen edist\u00e4miss\u00e4\u00e4ti\u00f6 sr, and the 3rd prize in NFKK Young Researcher Award 2024 competition. She also has a pending patent application WO2023187258 (A1)\u2014ASSAY FOR LONG FORMS OF CARDIAC TROPONIN T. MH has received consulting, lecturing and authoring fees from MSD and Bayer and support for congress attendance from AstraZeneca and Otsuka. NM has received support for congress attendance from AstraZeneca. TT has received consulting, lecturing and authoring fees from Boehringer-Ingelheim and support for congress attendance from AstraZeneca and CSL Vifor. He also holds a position of board member and fund manager (unpaid) in the Finnish Society of Nephrology. KM has received funding from Finska L\u00e4kares\u00e4llskapet and the Perklen foundation. TV has a pending patent application WO2023187258 (A1)\u2014ASSAY FOR LONG FORMS OF CARDIAC TROPONIN T. KEJA has received funding from the Finnish Foundation for Cardiovascular Research and consulting, lecturing and authoring fees from Bayer, Pfizer and Boehringer-Ingelheim. He also has a pending patent application WO2023187258 (A1)\u2014ASSAY FOR LONG FORMS OF CARDIAC TROPONIN T. SW has received grants or travel grants from the International Federation of Clinical Chemistry and Laboratory Medicine, Finnish Society of Clinical Chemistry, the Varsinais-Suomi Regional Fund of the Finnish Cultural Foundation, Turku University Foundation and the Finnish Foundation for Cardiovascular Research and research funding from Business Finland and the EFLM Cardiac Marker Award 2024. She also has a pending patent application WO2023187258 (A1)\u2014ASSAY FOR LONG FORMS OF CARDIAC TROPONIN T. TH has received consulting, lecturing and authoring fees from Astellas, AstraZeneca, GSK, MSD, Boehringer-Ingelheim and support for congress attendance from AstraZeneca. He also has a pending patent application WO2023187258 (A1)\u2014ASSAY FOR LONG FORMS OF CARDIAC TROPONIN T.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"159"}}